Alphatec Holdings, Inc. ATEC
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -68.25%
- 1 year
- -65.94%
5D -0.23 (-3.23%)
- Market cap
- 1.02B
- Revenue (ttm)
- 839.72M
- Profit margin
- -10.35%
- EPS (ttm)
- -0.57
- Shares out
- 153.33M
- Forward P/E
- 11.95
- YTD return
- -68.25%
- 1-year return
- -65.94%
- 50-day average
- 9.58
- 200-day average
- 9.97
- Volume
- 2.92M
- Avg volume
- 3.35M
- Open
- 6.79
- Previous close
- 6.90
- Day's range
- 6.63 – 7.00
- 52-week range
- 6.63 – 23.29
- Beta
- 0.87
- Analysts
- Strong Buy
- Price target
- 12.93 (+93.5%)
- Earnings date
- Feb 23, 2027
Key statistics
- Enterprise value
- 1.61B
- PEG ratio
- 0.48
- Price / sales
- 1.22
- Revenue growth
- 12.60%
- Free cash flow
- 29.95M
- Total cash
- 79.94M
- Total debt
- 593.95M
- Return on equity
- -308.06%
- Short % of float
- 10.74%
Fundamental scorecard
6 of 25 checks passed on ATEC’s reported financials
6of 25 checks passed
- Value 1 of 5
- Growth 3 of 5
- Profitability 1 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: strong buy
- Target (low)
- 8.00
- Target (mean)
- 12.93
- Target (high)
- 24.00
- Strong buy3
- Buy9
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate 0.11997.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | 0.12 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 0.09512 | 0.09 | -0.01 | -5.38% |
| Aug 4, 2026 | Jun 30, 2026 | 0.06946 | 0.07 | 0.00 | +0.78% |
| May 5, 2026 | Mar 31, 2026 | -0.01 | -0.22 | -0.21 | -2,100.00% |
| Feb 24, 2026 | Dec 31, 2025 | 0.04 | 0.06 | +0.02 | +50.00% |
| Oct 30, 2025 | Sep 30, 2025 | -0.03 | 0.03 | +0.06 | +200.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 11, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Nov 4, 2026 | UBS | down | Buy | Neutral |
| Oct 30, 2026 | Canaccord Genuity | main | Buy | Buy |
| Oct 30, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 30, 2026 | TD Cowen | main | Buy | Buy |
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- atecspine.com
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC HC Wainwright & Co. Maintains Buy on Alphatec Holdings, Lowers Price Target to $20
Freedom Capital Markets Maintains Buy on Alphatec Holdings, Lowers Price Target to $12
UBS Downgrades Alphatec Holdings to Neutral, Lowers Price Target to $8.5
JP Morgan Maintains Overweight on Alphatec Holdings, Lowers Price Target to $15
TD Cowen Maintains Buy on Alphatec Holdings, Lowers Price Target to $10
12 Health Care Stocks Moving In Friday's Intraday Session Wells Fargo Maintains Overweight on Alphatec Holdings, Lowers Price Target to $12
Crude Oil Gains 2%; ExxonMobil Posts Upbeat Earnings
Your note
Sign in to keep a note on ATEC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERKOWITZ MORTIMERIII | Director | Stock Award(Grant) | Jun 9, 2026 | 1,261,160 |
| HUNSAKER CRAIG E | Officer | Sale | Mar 8, 2026 | 1,725,610 |
| LISH SCOTT | Chief Operating Officer | Sale | Mar 12, 2026 | 815,704 |
| MARSHALL TYSON ELIOT | General Counsel | Sale | Aug 4, 2026 | 630,398 |
| MILES PATRICK S | Chief Executive Officer | Purchase | Sep 9, 2026 | 6,154,450 |
| PELIZZON DAVID R | Director | Stock Award(Grant) | Jun 9, 2026 | 10,773,900 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.09% | 10,991,957 | 73.32M | Sep 29, 2026 |
| Braidwell LP | 4.66% | 7,228,839 | 48.22M | Sep 29, 2026 |
| American Century Companies Inc | 4.15% | 6,433,302 | 42.91M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 3.36% | 5,216,227 | 34.79M | Sep 29, 2026 |
| BNP Paribas Asset Management Holding S.A. | 2.38% | 3,698,332 | 24.67M | Sep 29, 2026 |
| State Street Corporation | 2.30% | 3,574,463 | 23.84M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 3.12% | 4,842,212 | 32.30M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.35% | 3,649,925 | 24.34M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.06% | 3,198,455 | 21.33M | Sep 29, 2026 |
| VANGUARD WHITEHALL FUNDS-Vanguard Mid-Cap Growth Fund | 1.42% | 2,196,274 | 14.65M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.87% | 1,345,307 | 8.97M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.87% | 1,355,315 | 9.04M | Aug 30, 2026 |
